Shortcut Navigation:

Featured Clinical Trials

Learn what’s coming down the research pipeline, and find breast cancer clinical trials you may be eligible to participate in.

Phase III Trial Removes Primary Tumor in Metastatic Breast Cancer

A clinical trial seeks 880 participants to test whether removing the tumor in the breast in ­newly diagnosed metastatic breast cancer helps women who receive systemic therapy to live longer than those who receive systemic therapy alone. 

Observational Study Seeks Women with Metastatic HER2 Positive Breast Cancer

The new SystHERs (Systematic Therapies for HER2 positive Metastatic Breast Cancer Study) Registry seeks to enroll 1,000 people with HER2 positive metastatic breast cancer to analyze treatment patterns and outcomes. 

Trial Explores Anti-Estrogen Treatments and Chemotherapy

Researchers seek 4,000 participants for a clinical trial that will study whether hormonal therapy alone is adequate treatment for early-stage invasive breast cancer that traveled to one to three axillary lymph nodes and is found to be of low or intermediate risk for recurrence by genomic tests. 

Women Diagnosed Before 50 Needed for Study of Immune Response to Breast Cancer

A research study on immune response and suppression in different types of breast cancer seeks women diagnosed between the ages of 18 and 49 anywhere in the U.S.

Study of Ovarian Failure Needs Newly Diagnosed Young Women

Premenopausal women who are newly diagnosed with breast cancer and have not yet had chemotherapy are needed to participate in a study looking at biological factors that may relate to ovarian insufficiency after chemotherapy. 

Study of Tamoxifen and Ovarian Aging Needs Participants

Researchers are seeking to find out if hormonal therapy with tamoxifen affects ovarian function and age of menopause onset in women with breast cancer.

Trial to Investigate Benefits of Education and Exercise for Lymphedema

Researchers seek women newly diagnosed with stage I-III breast cancer planning to undergo axillary lymph node dissection for a study on preventing and treating lymphedema.

Trial May Advance Personalized Medicine

If you are newly diagnosed, find out whether you are eligible to participate in I-SPY2, a trial measuring the effectiveness of adding new medicines to standard chemotherapy given before surgery.

Trial Examines Optimal Treatments for HER2-Positive Early Breast Cancer

Phase III trial will compare lapatinib and trastuzumab in preventing recurrence of early-stage, HER2 positive breast cancer after surgery and chemotherapy.